Xiaolin Li
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Ferroptosis and cancer prognosis 8
- Lung Cancer Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 7
-
- RNA Interference and Gene Delivery 8
- Co-authors
- Huae Xu (30 shared papers)Dan Ding (10 shared papers)Xiaowei Lu (11 shared papers)Yong Hu (6 shared papers)Qiyun Tang (13 shared papers)Sunil Krishnan (3 shared papers)Wei‐Hao Sun (6 shared papers)Donghui Zheng (5 shared papers)
- Journals
- Oncotarget (3 papers)Acta Biochimica et Biophysica Sinica (3 papers)Radiotherapy and Oncology (3 papers)ACS Applied Materials & Interfaces (3 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Xiaolin Li
92 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 122
- Geriatrics and Gerontology 188
- Biomaterials 551
- Molecular Medicine 186
- Pharmaceutical Science 123
- Cancer Research 214
Countries citing papers authored by Xiaolin Li
This map shows the geographic impact of Xiaolin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Li more than expected).
Fields of papers citing papers by Xiaolin Li
This network shows the impact of papers produced by Xiaolin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Li. The network helps show where Xiaolin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 260 | |
| 2 | 2016 | 132 | |
| 3 | 2009 | 124 | |
| 4 | 2022 | 122 | |
| 5 | 2008 | 113 | |
| 6 | 2012 | 94 | |
| 7 | 2011 | 90 | |
| 8 | 2018 | 88 | |
| 9 | 2009 | 74 | |
| 10 | 2009 | 71 | |
| 11 | 2021 | 66 | |
| 12 | 2019 | 58 | |
| 13 | 2013 | 57 | |
| 14 | 2015 | 56 | |
| 15 | 2011 | 55 | |
| 16 | 2020 | 53 | |
| 17 | 2009 | 53 | |
| 18 | 2016 | 52 | |
| 19 | 2013 | 51 | |
| 20 | 2010 | 49 |
About Xiaolin Li
Xiaolin Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Epidemiology and Biomedical Engineering, having authored 99 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (8 papers), Ferroptosis and cancer prognosis (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Treatments and Mutations (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Geriatrics and Gerontology (188 citations), Biomaterials (551 citations), Molecular Medicine (186 citations), Pharmaceutical Science (123 citations) and Cancer Research (214 citations). Xiaolin Li has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Huae Xu, Dan Ding, Xiaowei Lu, Yong Hu, Qiyun Tang, Sunil Krishnan, Wei‐Hao Sun, Donghui Zheng, Baorui Liu and Xiqun Jiang. Their work appears in journals such as Oncotarget, Acta Biochimica et Biophysica Sinica, Radiotherapy and Oncology, ACS Applied Materials & Interfaces and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.